¿Por qué no se mejoran los niños con trastornos por déficit de atención con hiperactividad?
¿Why don´t inprove children with attention-deficit and hyperactivity disorder?
Palabras clave:
trastorno deficitario de atención con hiperactividad, psiquiatría infantil, estudios de seguimiento, prescripción de medicamentos (es)attention deficit disorder with hyperactivity, child psychiatry, follow-up studies, prescriptions, drug (en)
Introducción. Durante el año 2004, en consulta externa e interconsultas del servicio de psiquiatría infantil, se hicieron 1454 valoraciones, correspondientes a 592 pacientes. De éstas, 536 fueron por trastorno deficitario de atención con hiperactividad (TDAH), correspondientes a 240 pacientes. Se preguntó al paciente y familiares si la condición que motivó la consulta se encontraba mejor, peor o igual. Según el registro en el sistema, 76% estaban igual o peor; 23% mejor y 1% no contestó. Se hizo el estudio para determinar qué sucedió con aquellos cuyos registros estadísticos no mostraban mejoría.
Objetivo. Caracterizar los pacientes que asistieron a la consulta de psiquiatría infantil en quienes se hizo diagnóstico de TDAH y no reportaron mejoría clínica.
Material y métodos. Revisión de historias clínicas y entrevista personal con pacientes que consultaron al servicio de psiquiatría del Hospital Pediátrico de la Misericordia durante 2004 en quienes se hizo diagnóstico de TDAH y no reportaron mejoría clínica.
Resultados. En 237 pacientes con sospecha de TDAH se confirmó el diagnóstico en 157 (66.2%); se inició tratamiento a 114 (48.1%). Tras seguimiento, se encontró que 94 mejoraron y 20 lo abandonaron; tres expusieron sus motivos.
Conclusiones. Como informa la literatura internacional, se logró mejoría clínica en 82.45%. En quienes no mejoran se encuentran múltiples razones para explicar el abandono del tratamiento.
Background. During the year 2004, 1454 evaluations, corresponding to 592 patients, were made in outward and inter consultation. Out of these evaluations, 536 were because of ADD, corresponding to 240 patients. We asked the patients and their families whether, the children's condition that brought them to consultation had improved, was worse or the same. According to the registration system, 76% were the same or worse, 23% were better and 1% did not answer. We made a study in order to determine what had happened to the patients whose statistic registration showed no improvement. Objective. Characterizing the patients who came to consultation at the Children's Psychiatric consultation in the Hospital de la Misericordia during 2004 and who were diagnosed as ADD not reporting clinical improvement.
Material and methods. Patients who came to consultation at the Pediatric Psychiatric service of the Hospital de la Misericordia during the year 2004, who were diagnosed as ADD and did not report clinical improvement.
Results. In 237 patients suspicious of having ADD was confirmed in 157 patients (66%). Treatment was begun in 114 (48%). In the follow up studies, it was found that 94 improved, 20 abandoned the treatment; of these, three let give us their motivation.
Conclusions. We found mistakes in the patients' registration, specifically in the improvement indicator, and that frequently it was not possible to confirm diagnosis, nor initiate treatments, because the patients did not come back after the first consultation or abandoned the treatment.
As reported by international literature, there was 82.45% clinical improvement. Multiple reasons were found to explain abandonment of the treatment.
Descargas
Citas
American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales, texto revisado. DSM-IV-TR 2002: 45 - 154.
Organización Mundial de la Salud. Trastornos mentales y del comportamiento. Descripciones clínicas y pautas para el diagnóstico. CIE 10. 1992: 319 - 355.
Pelham WE. Pharmacotherapy for children with attention-deficit hyperactivity disorder. School Psychol Rev. 1993; 22: 199 - 227.
Richters JE, Arnold LE, Jensen P, Abikoff H, Conners CK, Greenhill LL. NIMH collaborative multisite multimodal treatment study of children with ADHD: I. Background and rationale. J Am Acad Child Adolesc Psychiatry 1995; 34: 987 - 1000.
The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attentiondeficit/ hyperactivity disorder. Arch Gen Psychiatry 1999; 56: 1073 - 1086.
Antshel KM, Remer R. Social skills training in children with attention deficit hyperactivity disorder: a randomized-controlled clinical trial. J Clin Child Ado-lesc Psychol. 2003; 32: 153 - 165.
The MTA Cooperative Group. Moderators and mediator of treatment response for children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56: 1088 - 1096.
Tutty S, Gephart H, Wurzbacher K. Enhancing behavioral and social skill functioning in children newly diagnosed with attention-deficit hyperactivity disorder in a pediatric setting. J Dev Behav Pediatr. 2003; 24: 51 - 57.
Klassen A, Miller A, Raina P, Lee S K, Olsen L. Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry 1999; 44: 1007 - 1016.
Montiel-Nava C, Peña JA, Espina-Mariñes G, Ferrer-Hernández ME, López-Rubio A, Puertas-Sánchez S, Cardozo-Durán JJ. Estudio piloto de metilfenidato y entrenamiento a padres en el tratamiento de niños con trastorno por déficit de atención-hiperactividad. Rev Neurol 2002; 35: 201 - 205.
Gadow KD, Nolan EE, Sverd J, Sprafkin J, Paolicelli L. Methylphenidate in aggressive-hiperactivity boys. I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiatry 1990;29: 710 - 718.
Charach A, Ickowicz A, Schachar R Stimulant treatment over five years: adherence, effectiveness, and adverse effects. J Am Acad Child Adolesc Psychiatry. 2004; 43: 559-567.
Lambert NM. Adolescent Outcomes for Hyperactive Children. Perspectives on General and Specific Patterns of Chidhood Risk for Adolescent Educational, Social, and Mental Health Problems. American Psychologist 1988; 43: 786 - 799.
Hinshaw SP. Academia underachievement, attention deficits, and agresión: comorbidity and implications for intervención. J Consul Clin Psychol 1992; 60: 893-903.
Pliszka SR, Carlson CL, Swanson JM. ADHD with conmorbid disorders. Clinical assessment and management. New York: The Guilford Press; 1999.
Newcorn JH, Spencer TJ, Biederman J, Milton DR, Michelson D. Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. J Am Acad Child Adolesc Psychiatry. 2005; 44:240 -248.
Hinshaw S. Academic Underachievement, Attention Deficits, and Aggression: Comorbidity and Implications for Intervention. Journal Of Consulting and Clinical Psychology. 1992, 60: 893 - 903.
Biederman J, Faraone SV, Monuteaux MC, Grossbard JR. How informative are parent reports of attention-deficit/hyperactivity disorder symptoms for assessing outcome in clinical trials of long-acting treatments? A pooled analysis of parents' and teachers' reports. Pediatrics. 2004; 113: 1667 - 1671.
Silvertone PH, Salsali M. Low self-esteem and psychiatric patients: Part I: The relationship between low self-esteem and psychiatric diagnosis. Annals of General Hospital Psychiatry 2003; 2: 2.
MTA Cooperative Group. Nacional Institute of Mental Health Multimodal Tratament Study of ADHD Follow-up: 24-Month Outcomes of Tratament Strategies for Attention-Deficit/Hyperactivity Disorder. Pediatrics 2004; 113: 754 - 761.
Wilens TE, Faraone SV, Biederman J, Gunawardene. Does Stimulant Therapy of Attention-Deficit/ Hyperactivity Disorder Beget Later Substance Abuse? AS Meta-analytic Review of the Literature. Pediatrics 2003; 111: 179 - 185.
Mannuzza S, Klein RG, Moulton JL 3rd. Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective followup study. J Child Adolesc Psychopharmacol. 2003; 13: 273 - 282.
MTA Coopeative Group. Nacional Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in Effectiveness and Growth Alter the End of Treatment. Pediatrics 2004; 113: 762 - 769.
Hoza B, Gerdes AC, Mrug S, Hinshaw SP, Bukowski WM, Gold JA, Arnold LE, Abikoff HB, Conners CK, Elliott GR, Greenhill LL, Hechtman L, Jensen PS, Kraemer HC, March JS, Newcorn JH, Severe JB, Swanson JM, Vitiello B, Wells KC, Wigal T. Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder. J Clin Child Adolesc Psychol. 2005; 34: 74 - 86.
Abikoff H, Klein RG. Attention-Deficit Hyperactivity and Conduct Disorder: Comorbidity and Implications for Treatment. Journal Of Consulting and Clinical Psychology. 1992, 60: 881 - 892.
Licencia
Derechos de autor 2005 Revista de la Facultad de Medicina

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
-